Pre-amplified dsDNA-Tag lateral flow assay for highly sensitive point-of-care detection of influenza A H1N1
Biochimie · 2026
DOI: 10.1016/j.biochi.2026.01.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimie, 2026. Verfasst von Lingling Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, 130122, China; College of Life Sciences, Jilin Agricult…. Hauptthemen laut MEDLINE: Influenza A Virus, H1N1 Subtype, Point-of-Care Systems, Influenza, Human, Biosensing Techniques. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Jilin Province Development and Reform Commission, Department of Science and Technology of Jilin Province.
Abstract (Originalsprache)
The current immediate detection of influenza A (H1N1) virus faces the dual challenges of insufficient sensitivity and the risk of amplification contamination. Here, we developed a novel lateral flow nucleic acid biosensor using pre-amplified dsDNA tag (PADT). Linearized M13 phage was preamplified to generate a 3.5-kbp dsDNA product containing a 20-nt overhang probe and heavy biotin tags, followed by the formation of FAM probe/target RNA/PADT complexes by a sandwich-type detection strategy. RESULT: This technique achieves a 1 pM detection limit for H1N1-specific RNA, demonstrating 100-fold greater sensitivity than conventional lateral flow chromatography (p < 0.01). This method eliminates nucleic acid amplification, preventing false positives from amplicon contamination. This method effectively prevents false positives induced by product contamination by avoiding direct amplification of the target nucleic acid. This stepwise strategy, marrying pre-amplification with point-of-need detection, achieves laboratory-grade accuracy while maintaining field applicability. The step-by-step strategy of pre-amplification and immediate detection combines laboratory precision with field applicability, and the design of interchangeable overhangs provides a platform solution for multi-virus detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, 130122, China; College of Life Sciences, Jilin Agricultural University, Changchun, 130118, China.
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, 130122, China; College of Life Science, Ningxia University, Yinchuan, 750021, China.
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, 130122, China; School of Life Science and Technology, Changchun University of Science and Technology, Changchun, 130022, Chin…
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, 130122, China.
- College of Life Science, Ningxia University, Yinchuan, 750021, China.
- School of Life Science and Technology, Changchun University of Science and Technology, Changchun, 130022, China.
Förderung
- Jilin Province Development and Reform Commission
- Department of Science and Technology of Jilin Province
Zitieren
APA
Wang, L., Zhou, H., Bu, S., Chen, J., Xing, H., Hao, Z., Zhou, X., Pang, C., Su, Y., & Wan, J. (2026). Pre-amplified dsDNA-Tag lateral flow assay for highly sensitive point-of-care detection of influenza A H1N1. Biochimie. https://doi.org/10.1016/j.biochi.2026.01.006
Vancouver
Wang L, Zhou H, Bu S, Chen J, Xing H, Hao Z, et al. Pre-amplified dsDNA-Tag lateral flow assay for highly sensitive point-of-care detection of influenza A H1N1. Biochimie. 2026. doi:10.1016/j.biochi.2026.01.006
BibTeX
@article{Wang2026,
author = {Wang, Lingling and Zhou, Hongyu and Bu, Shengjun and Chen, Jingyou and Xing, Haiyang and Hao, Zhuo and Zhou, Xuezhang and Pang, Chunying and Su, Yuchun and Wan, Jiayu},
title = {Pre-amplified dsDNA-Tag lateral flow assay for highly sensitive point-of-care detection of influenza A H1N1},
journal = {Biochimie},
year = {2026},
doi = {10.1016/j.biochi.2026.01.006}
}
EUVIMED